Maxim Totrov

USPTO Granted Patents = 23 (Patent Applications = 1)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 5.8

ph-index = 11

Forward Citations = 342(Granted Patents)

Location History:

San Deigo, CA (US) (2014)
San Diedo, CA (US) (2015)
San Diego, CA (US) (2011 - 2023)

Company Filing History:

14 out of 27

Rempex Pharmaceuticals, Inc.

Melinta Subsidiary Corp.

patents

5. 2 out of 1,551

University of Massachusetts

Icahn School of Medicine at Mount Sinai

patents

where one patent can have more than one assignee

Years Active: 2011-2024

Loading Chart...

23 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12171772 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2024-12-24),

2. 11684629 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2023-06-27),

3. 11090319 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2021-08-17),

4. 10639318 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2020-05-05),

5. 10568969 - Immunogenic polypeptides (2020-02-25),

6. 10206937 - Boronic acid derivatives and therapeutic uses thereof (2019-02-19),

7. 10183034 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2019-01-22),

8. 10172874 - Pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2019-01-08),

9. 10004758 - Cyclic boronic acid ester derivatives and methods of making the same (2018-06-26),

10. 9963467 - Boronic acid derivatives and therapeutic uses thereof (2018-05-08),

11. 9694025 - Cyclic boronic acid ester derivatives and therapeutic uses thereof (2017-07-04),

12. 9642869 - Boronic acid derivatives and therapeutic uses thereof (2017-05-09),

13. 9534020 - Immunogenic polypeptides comprising a modified loop peptide presenting the HIV-1 GP120 3074 mAb epitope and scaffold proteins containing said peptide (2017-01-03),

14. 9296763 - Cyclic boronic acid ester derivatives and therapeutic uses thereof (2016-03-29),

15. 9241947 - Boronic acid derivatives and therapeutic uses thereof (2016-01-26),

Title: Maxim Totrov: Pioneering Innovations in Pharmaceutical Compositions

Introduction

Maxim Totrov, based in San Diego, California, is a renowned inventor with a significant contribution to the field of pharmaceuticals. With an impressive portfolio of 23 patents, Totrov is recognized for his innovative approaches to developing therapeutic agents. His work primarily revolves around antimicrobial compounds, paving the way for breakthroughs in medicine.

Latest Patents

Among his latest patents, Totrov has focused on the therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives. These patents detail antimicrobial compounds and their formulations, elucidating both the use and preparation of these innovative pharmaceutical compositions. The cyclic boronic acid ester derivatives have been shown to serve as effective therapeutic agents, highlighting Totrov's commitment to advancing healthcare solutions.

Career Highlights

Maxim Totrov has a robust career with notable positions at various esteemed companies. He has worked at Rempex Pharmaceuticals, Inc. and Molsoft LLC, where he has contributed to substantial research and development in the pharmaceutical industry. His career is distinguished by the pursuit of novel therapeutic agents, underscoring his role as a leader in medicinal innovations.

Collaborations

Throughout his career, Totrov has collaborated with other prominent professionals in the industry, including Scott J. Hecker and Raja K. Reddy. These partnerships have fostered a productive environment for innovation, allowing for the exchange of ideas and expertise essential for developing groundbreaking pharmaceutical solutions.

Conclusion

Maxim Totrov exemplifies the spirit of innovation in the field of pharmaceuticals with his extensive patent portfolio and collaborative efforts. His work with cyclic boronic acid ester derivatives stands as a testament to his dedication to improving therapeutic strategies. As he continues to push the boundaries of science, Totrov's impact on the industry promises to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.